SEOUL, South Korea, Nov. 19, 2025 /PRNewswire/ -- ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent and Trademark Office has ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a once-and-done treatment paradigm for diseases with ...
News Medical on MSN
Leukemia That Starts Before Birth Is More Aggressive
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
AZoLifeSciences on MSN
Gene scissors in camouflage mode help in the search for cancer therapies
The immune system plays a crucial role in fighting tumours and metastases. Consequently, it is decisive to conduct cancer research in mouse models with an immune system that is as natural as possible ...
In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...
Cardiologist and Men's Health advisory board member Christopher Kelly, MD, says this treatment is "approaching magic" for people with high cholesterol. "It’s definitely where the future of medicine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback